|
Market Cap (18-May) $14,687,399 (777th) |
Close (30-Jun) $0.018 |
Volume (30-Jun) 1,123,417 |
Shortsold (11-Sep) 1,800,000 (0.12%) (439th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.00 |
EPS -0.02 |
BNO released this announcement to the ASX on 29 July 2021, 8:57. The announcement is marked as price sensitive, and is 10 page(s) in length and 247.97kb in size.
You can view all announcements from BNO and see how they appear on a price chart on the announcements page.
At the date of this announcement, BNO was 0.002% short sold according to ASIC data. It was ranked the 656th most shorted stock on the ASX. It is now ranked as the 439th most shorted stock on the ASX with 0.123% of total shares short sold as of the latest reported data (11 September 2023).
| Other Recent Announcements from BNO | |
|---|---|
| Poster Presentation at the ASCP Annual Meeting | 1 June 2023, 9:16 |
| Corporate Presentation - May 2023 | 23 May 2023, 9:24 |
| BNO announces establishment of At-The-Market Equity Program | 8 May 2023, 8:54 |
| Quarterly Activities and Cashflow Report | 29 July 2021, 8:57 |
| Final Director's Interest Notice | 19 July 2021, 15:37 |
| BNO Initiates Phase 2b ATTUNE Study of BNC210 in PTSD | 6 July 2021, 9:24 |
| Initial Director's Interest Notice M. Davies | 1 July 2021, 14:33 |
You must be logged in to post a reply.
Bionomics 